- Home
- OCSL vs ICUCW Comparison
OCSL vs ICUCW Comparison
Compare OCSL & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCSL
- ICUCW
- Stock Information
- Founded
- OCSL 2007
- ICUCW N/A
- Country
- OCSL United States
- ICUCW United States
- Employees
- OCSL N/A
- ICUCW 19
- Industry
- OCSL Finance: Consumer Services
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- OCSL Finance
- ICUCW Health Care
- Exchange
- OCSL Nasdaq
- ICUCW Nasdaq
- Market Cap
- OCSL 1.2B
- ICUCW N/A
- IPO Year
- OCSL 2008
- ICUCW 2021
- Fundamental
- Price
- OCSL $14.12
- ICUCW N/A
- Analyst Decision
- OCSL Hold
- ICUCW
- Analyst Count
- OCSL 7
- ICUCW 0
- Target Price
- OCSL $16.00
- ICUCW N/A
- AVG Volume (30 Days)
- OCSL 674.0K
- ICUCW N/A
- Earning Date
- OCSL 08-05-2025
- ICUCW N/A
- Dividend Yield
- OCSL 11.37%
- ICUCW N/A
- EPS Growth
- OCSL N/A
- ICUCW N/A
- EPS
- OCSL 0.11
- ICUCW N/A
- Revenue
- OCSL $353,866,000.00
- ICUCW N/A
- Revenue This Year
- OCSL N/A
- ICUCW N/A
- Revenue Next Year
- OCSL N/A
- ICUCW N/A
- P/E Ratio
- OCSL $129.50
- ICUCW N/A
- Revenue Growth
- OCSL N/A
- ICUCW N/A
- 52 Week Low
- OCSL $12.50
- ICUCW N/A
- 52 Week High
- OCSL $18.87
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- OCSL 53.19
- ICUCW N/A
- Support Level
- OCSL $13.47
- ICUCW N/A
- Resistance Level
- OCSL $14.03
- ICUCW N/A
- Average True Range (ATR)
- OCSL 0.24
- ICUCW 0.00
- MACD
- OCSL 0.02
- ICUCW 0.00
- Stochastic Oscillator
- OCSL 59.29
- ICUCW 0.00
About OCSL Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.